Marie-Andrée Yessine

Marie-Andrée Yessine has held a variety of roles in the pharmaceutical industry since 2007. From 2007 to 2013, they were a Sr Scientist, Science board, Sr Scientist, Formulation & process development, and Formulation Scientist at Dr. Reddy's Laboratories. During this time, they were responsible for supporting R&D projects with respect to product development strategy, conveying knowledge and direction to other employees, and developing and implementing Quality by Design framework, standards and best practices. From 2013 to 2022, they were a Sr Scientist Formulation and Process development and a Formulation Scientist at OctoPlus. In this role, they were responsible for project lead pre-clinical product development, process development, and supporting the business development group in the acquisition of new projects. Currently, they are the Director Drug product development and Director CMC at ISA Pharmaceuticals.

Marie-Andrée Yessine received their Bacheler in Pharmacy from Université Laval between 1996 and 2000. Marie-Andrée then went on to pursue their Ph.D. in Pharmaceutical Sciences and Pharmaceutical Technology at Université de Montréal, which they completed in 2006. In February 2019, they obtained a certification from Hubert Consult for Confidant inappropriate behaviors at work / Vertrouwenspersoon ongewenste omgangsvormen.